Closing of Flow-Through Private Placement and Public Offering of Common Shares for Gross Proceeds of Approximately C$138 Million
/NOT FOR RELEASE TO U.S. NEWS WIRE SERVICES OR DISTRIBUTION IN THE UNITED STATES/ MONTREAL, Feb. 20, 2026 /PRNewswire/ -- February 20, 2026 – Sydney, Australia Highlights Successful closing of the previously announced financings, strengthening...
CGTN: Private economy: A key actor in advancing China's economic priorities in 2026 and beyond
BEIJING, Feb. 18, 2026 /PRNewswire/ -- CGTN published an article exploring the Chinese private sector's pivotal role in advancing the priorities of the country's current economic work. The article highlights the significant achievements of private...
Catwalk Entertainment Group signs HK director for Pan-Asian push, propels C-pop to global NBA stage
TAIPEI, Feb. 13, 2026 /PRNewswire/ -- Catwalk Entertainment Group, the premier Pan-Asian entertainment conglomerate, today announced a strategic partnership with acclaimed Hong Kong director and screenwriter Tze Yiu Chui. The alliance marks a major...
A 45-year bond: tesa drives innovation and sustainable growth in Singapore
Collaboration with impact – Turning partnerships into regional innovation for Singapore's next phase of growth Innovating for tomorrow – Developing next-gen adhesive solutions that meet future industry needs Building sustainable progress – Advancing...
Top 10 News Stories on 2025 Lancang-Mekong Cooperation Released in Luang Prabang
LUANG PRABANG, Laos, Feb. 5, 2026 /PRNewswire/ -- A report by China Report ASEAN: The list of Top 10 News Stories on 2025 Lancang-Mekong Cooperation was officially released on the evening of February 4 (Beijing time) in Luang Prabang, Laos,...
Nona Biosciences Co-founds Innovative Alliance for Translational Medicine in Immunological Diseases, Advancing a New IIT-Driven Ecosystem
CAMBRIDGE, Mass., Jan. 29, 2026 /PRNewswire/ -- Recently, as a core co-founder and co-organizer, Nona Biosciences participated in the launch of the "Innovative Alliance for Translational Medicine in Immunological Diseases" (the "Alliance") and...
Nanoscope Secures Japan MHLW Sakigake and Orphan Drug Designations Across Inherited Retinal Diseases - A First for a Retinal Gene Therapy
Japan's Ministry of Health, Labour and Welfare (MHLW) grants MCO-010 Sakigake (Pioneering Regenerative Medical Product) and Orphan Drug designations, enabling an accelerated regulatory pathway for patients with severe inherited retinal diseases...
Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development
- In head-to-head non-human primate (NHP) studies, average observed half-life of ASC37 was approximately 17 days, 7-fold longer than retatrutide, which supports once-monthly subcutaneous (SQ) dosing in humans. - ASC37's average in vitro activity was...
A Strategic Milestone: PhotonPay Secures U.S. MTL License to Anchor Its Global Regulatory Framework
HONG KONG, Jan. 19, 2026 /PRNewswire/ -- PhotonPay, a leading global digital financial infrastructure platform, has obtained Money Transmitter License (MTL) from state financial regulatory authority in the United States. Through the successful...
FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene's NouvNeu001, Making It the World's First iPSC Therapy with Both FTD and RMAT Recognitions
Designation underscores potential of chemically induced, off-the-shelf cell therapy to address high unmet need in Parkinson's disease, following compelling Phase I clinical data CHENGDU, China, Jan. 19, 2026 /PRNewswire/ -- iRegene Therapeutics Co.,...